Bronchoalveolar Activation of Coagulation and Inhibition of Fibrinolysis during Ventilator-Associated Lung Injury

Background and Objective. Bronchoalveolar coagulopathy is a characteristic feature of pulmonary inflammation. We compared bronchoalveolar and systemic levels of coagulation in patients who did and patients who did not develop ventilator-associated lung injury (VALI). Methods. Secondary analysis of a...

Full description

Saved in:
Bibliographic Details
Main Authors: M. J. Schultz, R. M. Determann, A. A. N. M. Royakkers, E. K. Wolthuis, J. C. Korevaar, M. M. Levi
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Critical Care Research and Practice
Online Access:http://dx.doi.org/10.1155/2012/961784
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832550912272367616
author M. J. Schultz
R. M. Determann
A. A. N. M. Royakkers
E. K. Wolthuis
J. C. Korevaar
M. M. Levi
author_facet M. J. Schultz
R. M. Determann
A. A. N. M. Royakkers
E. K. Wolthuis
J. C. Korevaar
M. M. Levi
author_sort M. J. Schultz
collection DOAJ
description Background and Objective. Bronchoalveolar coagulopathy is a characteristic feature of pulmonary inflammation. We compared bronchoalveolar and systemic levels of coagulation in patients who did and patients who did not develop ventilator-associated lung injury (VALI). Methods. Secondary analysis of a randomized controlled trial evaluating the effect of lower tidal volumes versus conventional tidal volumes in patients without acute lung injury or acute respiratory distress syndrome at the onset of mechanical ventilation. Results. Ten patients with VALI and 10 random control patients without lung injury during the course of mechanical ventilation, but all ventilated with conventional tidal volumes, were compared. Patients who developed VALI showed both bronchoalveolar activation of coagulation (increase in thrombin–antithrombin complex levels P<0.001 versus baseline) and inhibition of fibrinolysis (decline in plasminogen activator activity P<0.001 versus baseline). The later seemed to be dependent on higher levels of plasminogen activator inhibitor type 1 (P=0.001 versus baseline). Patients who developed VALI also showed elevated systemic thrombin-antithrombin complex levels and decreased systemic plasminogen activator activity levels. Conclusions. VALI is characterized by bronchoalveolar coagulopathy. Systemic and bronchoalveolar coagulopathy at the onset of mechanical ventilation may be a risk factor for developing VALI in patients ventilated with conventional tidal volumes.
format Article
id doaj-art-712324377b874558955b526628a333dd
institution Kabale University
issn 2090-1305
2090-1313
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Critical Care Research and Practice
spelling doaj-art-712324377b874558955b526628a333dd2025-02-03T06:05:24ZengWileyCritical Care Research and Practice2090-13052090-13132012-01-01201210.1155/2012/961784961784Bronchoalveolar Activation of Coagulation and Inhibition of Fibrinolysis during Ventilator-Associated Lung InjuryM. J. Schultz0R. M. Determann1A. A. N. M. Royakkers2E. K. Wolthuis3J. C. Korevaar4M. M. Levi5Department of Intensive Care Medicine, Academic Medical Center, Meibergdreef 9, Amsterdam, 1105 AZ, The NetherlandsDepartment of Intensive Care Medicine, Academic Medical Center, Meibergdreef 9, Amsterdam, 1105 AZ, The NetherlandsDepartment of Anesthesiology, Tergooi Ziekenhuizen, Rijksstraatweg 1, Blaricum, 1261 AN, The NetherlandsDepartment of Anesthesiology, Academic Medical Center, Meibergdreef 9, Amsterdam, 1105 AZ, The NetherlandsDepartment of Biostatistics and Epidemiology, Academic Medical Center, Meibergdreef 9, Amsterdam, 1105 AZ, The NetherlandsDepartment of Internal Medicine, Academic Medical Center, Meibergdreef 9, Amsterdam, 1105 AZ, The NetherlandsBackground and Objective. Bronchoalveolar coagulopathy is a characteristic feature of pulmonary inflammation. We compared bronchoalveolar and systemic levels of coagulation in patients who did and patients who did not develop ventilator-associated lung injury (VALI). Methods. Secondary analysis of a randomized controlled trial evaluating the effect of lower tidal volumes versus conventional tidal volumes in patients without acute lung injury or acute respiratory distress syndrome at the onset of mechanical ventilation. Results. Ten patients with VALI and 10 random control patients without lung injury during the course of mechanical ventilation, but all ventilated with conventional tidal volumes, were compared. Patients who developed VALI showed both bronchoalveolar activation of coagulation (increase in thrombin–antithrombin complex levels P<0.001 versus baseline) and inhibition of fibrinolysis (decline in plasminogen activator activity P<0.001 versus baseline). The later seemed to be dependent on higher levels of plasminogen activator inhibitor type 1 (P=0.001 versus baseline). Patients who developed VALI also showed elevated systemic thrombin-antithrombin complex levels and decreased systemic plasminogen activator activity levels. Conclusions. VALI is characterized by bronchoalveolar coagulopathy. Systemic and bronchoalveolar coagulopathy at the onset of mechanical ventilation may be a risk factor for developing VALI in patients ventilated with conventional tidal volumes.http://dx.doi.org/10.1155/2012/961784
spellingShingle M. J. Schultz
R. M. Determann
A. A. N. M. Royakkers
E. K. Wolthuis
J. C. Korevaar
M. M. Levi
Bronchoalveolar Activation of Coagulation and Inhibition of Fibrinolysis during Ventilator-Associated Lung Injury
Critical Care Research and Practice
title Bronchoalveolar Activation of Coagulation and Inhibition of Fibrinolysis during Ventilator-Associated Lung Injury
title_full Bronchoalveolar Activation of Coagulation and Inhibition of Fibrinolysis during Ventilator-Associated Lung Injury
title_fullStr Bronchoalveolar Activation of Coagulation and Inhibition of Fibrinolysis during Ventilator-Associated Lung Injury
title_full_unstemmed Bronchoalveolar Activation of Coagulation and Inhibition of Fibrinolysis during Ventilator-Associated Lung Injury
title_short Bronchoalveolar Activation of Coagulation and Inhibition of Fibrinolysis during Ventilator-Associated Lung Injury
title_sort bronchoalveolar activation of coagulation and inhibition of fibrinolysis during ventilator associated lung injury
url http://dx.doi.org/10.1155/2012/961784
work_keys_str_mv AT mjschultz bronchoalveolaractivationofcoagulationandinhibitionoffibrinolysisduringventilatorassociatedlunginjury
AT rmdetermann bronchoalveolaractivationofcoagulationandinhibitionoffibrinolysisduringventilatorassociatedlunginjury
AT aanmroyakkers bronchoalveolaractivationofcoagulationandinhibitionoffibrinolysisduringventilatorassociatedlunginjury
AT ekwolthuis bronchoalveolaractivationofcoagulationandinhibitionoffibrinolysisduringventilatorassociatedlunginjury
AT jckorevaar bronchoalveolaractivationofcoagulationandinhibitionoffibrinolysisduringventilatorassociatedlunginjury
AT mmlevi bronchoalveolaractivationofcoagulationandinhibitionoffibrinolysisduringventilatorassociatedlunginjury